Eric Padron, MD is an Associate Member and Scientific Director of the Department of Hematology at Moffitt Cancer Center (MCC). He completed a hematology oncology fellowship and was recruited to MCC in 2013. Dr. Padron’s research focus has centered on studying clonal hematopoiesis (CH) and chronic myeloid neoplasms across the translational research spectrum. Importantly, he has published seminal work establishing key biologic features, novel treatments, and clinical trials in CMML. Further, Dr. Padron is an R37 MERIT awardee from the National Cancer Institute (NCI) for his work in chronic myelomonocytic leukemia and has published more than 175 peer reviewed articles describing advances in myeloid malignancies and hematologic conditions, including CH. Dr. Padron is among the few physician-scientists with experience both in leading multi-institution trials and a successful NCI funded laboratory making him uniquely suited to lead this proposal.